<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE AND PATIENTS AND METHODS: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo>, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> antibodies to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, and a false-positive result on testing for <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> have been linked to thrombotic <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e>, particularly in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease, i.e., patients not fulfilling four American <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">Rheumatism</z:e> Association criteria for the classification of SLE </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical and serologic features of 35 patients with cerebrovascular disease (<z:hpo ids='HP_0001297'>strokes</z:hpo>/<z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo>) who demonstrated antibodies to <z:chebi fb="1" ids="16247">phospholipids</z:chebi> are presented </plain></SENT>
<SENT sid="2" pm="."><plain>Complete histories were obtained from <z:hpo ids='HP_0000001'>all</z:hpo> 35 patients, and <z:hpo ids='HP_0000001'>all</z:hpo> underwent routine physical examinations, radiography, electrocardiography, computed tomographic brain scanning, and immunologic studies </plain></SENT>
<SENT sid="3" pm="."><plain>Psychometric tests were performed in nine patients </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The <z:hpo ids='HP_0001297'>strokes</z:hpo> were often multiple and were followed by multi-<z:mpath ids='MPATH_124'>infarct</z:mpath> <z:hpo ids='HP_0000726'>dementia</z:hpo> in nine patients </plain></SENT>
<SENT sid="5" pm="."><plain>Of particular interest were 10 patients in whom the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> was the major and often the sole immunologic disturbance present </plain></SENT>
<SENT sid="6" pm="."><plain>Several of these patients were antinuclear antibody-negative, and the <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo>, when present, were usually of a low titer (1:40 to 1:160) </plain></SENT>
<SENT sid="7" pm="."><plain>These patients conform to a group classified as having a <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> are strongly associated with <z:e sem="disease" ids="C0596298" disease_type="Disease or Syndrome" abbrv="">cerebrovascular occlusions</z:e> in patients with SLE as well as in those with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease and the <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with any of these conditions who present with vascular events should be screened for these antibodies, as their occurrence may have a bearing on future therapy </plain></SENT>
</text></document>